封面
市場調查報告書
商品編碼
2166759

獸醫分子診斷系統市場:全球市場預測,2026-2032年

Veterinary Molecular Diagnostic System Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,獸醫分子診斷市場規模將達到 25.4 億美元,複合年成長率為 9.41%。

主要市場統計數據
基準年 2025 13.5億美元
預計年份:2026年 14.8億美元
預測年份 2032 25.4億美元
複合年成長率 (%) 9.41%

獸醫分子診斷:概述

獸醫分子診斷系統利用核酸檢測及相關分子技術來檢測動物體內的病原體、遺傳疾病和具有臨床意義的生物標記。當快速、特異性的檢測結果能夠支持治療方案的選擇、畜群管理、疫情應對、食物鏈保護以及伴侶動物、家畜、水產養殖和野生動物等領域的監測時,其價值尤為顯著。

向更快、更分散的獸醫檢測過渡

目前情勢正從集中式、實驗室密集的工作流程轉向整合樣品製備、擴增、檢測和報告的系統,同時減少人工操作。快速結果的需求進一步受到以下因素的驅動:對抗生素抗藥性、跨國動物疫病、生物安全要求以及在生產環境中管理高通量篩檢的需求。實施的成功還取決於檢體品質、跨物種檢驗、工作流程互通性、操作人員培訓、保險報銷條件以及監管部門的批准。

利用人工智慧增強口譯和工作流程管理

人工智慧(AI)可透過輔助影像和訊號解讀、品管檢查、異常檢測、流行病學模式識別以及確診試驗的優先排序來增強分子診斷。其實際應用取決於具有代表性的獸醫資料集、透明的檢驗、人工監督、網路安全以及與檢查室資訊系統的整合。因此,人工智慧最適合作為輔助手段,提高診斷的一致性和分診效率,而非取代檢驗的檢測方法或獸醫的判斷。

區域差異反映了疾病負擔、基礎設施和法規。

北美擁有先進的獸醫基礎設施、完善的檢查室網路以及對伴侶動物和牲畜檢測的強勁需求。歐洲強調動物健康監測、可追溯性、合理使用抗菌藥物和統一標準,而亞太地區則兼具高度都市區的診斷能力和快速發展的生產體系,但各地區的檢查室能力卻不盡相同。拉丁美洲高度重視牲畜健康、出口保障和疫情監測。中東在牲畜生產、進口管制和跨國疾病防範方面面臨獨特的挑戰。非洲為分散式和本地化系統提供了巨大的發展機遇,但成本效益、物流、可靠的電力供應以及檢測實驗室的可及性仍然是實施過程中需要考慮的關鍵因素。

集團層面的優先事項驅動採購和部署。

東協的優先事項包括跨境監測、水產養殖和畜牧業健康,以及適用於不同檢測環境的解決方案。金磚國家的需求多種多樣,涵蓋了大規模生產系統和公共獸醫服務到研究能力以及獲得先進檢測服務的差異。歐盟強調監測系統的協調、食品安全和監管一致性。七國集團(G7)國家普遍支持先進的診斷技術、品管系統和資料整合。海灣合作理事會(GCC)國家優先考慮進口生物安全、畜牧業生產力以及集中或協調的檢測網路。北約成員國也可能強調應對影響動物健康、糧食安全和運作韌性的生物威脅的準備工作。然而,國家法規和採購慣例仍然是決定性因素。

來自觀點國家的多種應用案例

澳洲優先考慮生物安全、牲畜監測和地理分散的檢測。巴西將大規模畜禽養殖系統與出口導向診斷和疫情控制需求結合。加拿大和美國支持伴侶動物、肉類動物、研究以及公共部門的先進應用。中國和印度在生產動物、水產養殖、獸醫院和監測計畫方面需求廣泛,但基礎設施因地區而異。日本和韓國優先考慮品質、速度和技術驅動的臨床工作流程。法國、德國、義大利、西班牙和英國正在將分子檢測與動物衛生服務、食品鏈保障、研究和監管監測相結合。墨西哥優先考慮牲畜健康、貿易相關檢測以及改善對當地地區的訪問。俄羅斯的需求包括大規模生產監測、獸醫管理以及地理分散系統的韌性。

優先考慮經過檢驗、整合且可在現場立即使用的診斷工作流程。

產業領導者首先必須確保檢測項目和設備規格與明確定義的物種、疾病、檢體類型和決策時間表相符。他們還應建立現場性能檢驗、品管和確認測試流程,並根據整個工作流程的需求(而不僅僅是設備的功能)制定採購計劃。與獸醫實驗室、大學、生產商和公共衛生機構夥伴關係可以增強證據產生和監測的效用。投資於可互通的報告系統、人才培養、維護支援、供應鏈連續性、網路安全和負責任的人工智慧管治,有助於將技術能力轉化為可靠的臨床和人群健康結果。

基於證據的獸醫診斷評估調查方法

本執行摘要系統地回顧了獸醫分子診斷系統的現狀,重點關注技術應用、動物健康工作流程、監管和監測需求、基礎設施狀況以及區域推廣因素。摘要整合了來自檢驗的公開訊息,包括政府和政府間機構的指導意見、同行評審的研究、監管文件、檢查室標準以及已記錄的獸醫實踐模式。為避免不實假設,摘要採用定性描述,並結合疾病控制重點、生產系統、檢查室能力和政策環境的差異,對區域、群體和國家層面的觀察結果進行解讀。

可靠的分子檢測有助於建立更健全的動物健康體系。

獸醫分子診斷系統在及時發現疾病、進行精準干預、合理使用抗生素、保障生物安全和進行協同監測方面正變得日益重要。當檢驗的檢測方法、可操作的工作流程、整合的資料系統和訓練有素的使用者與本地疾病知識和永續的服務模式相結合時,最大的機會可能就會出現。未來的發展更取決於它與獸醫實踐、監管要求、基礎設施以及不同動物健康環境的實際運作情況的契合程度,而非技術本身。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章 獸醫分子診斷系統市場:依疾病類別分類

  • 遺傳性疾病
  • 感染疾病
    • 細菌
      • 大腸桿菌
      • 分枝桿菌
      • 沙門氏菌
    • 真菌
    • 寄生
    • 病毒性的
      • 禽流感
      • 馬傳染性貧血
      • 豬繁殖呼吸綜合症
  • 代謝性疾病
  • 腫瘤診斷

第8章 獸醫分子診斷系統市場:依技術分類

  • 等溫擴增
  • 次世代定序
  • PCR
    • 常規PCR
    • 數位PCR
    • 即時PCR

第9章 獸醫分子診斷系統市場:依目標動物類型分類

  • 伴侶動物
    • 狗
    • 馬
    • 貓
  • 家畜
    • 牛
    • 豬
    • 家禽

第10章 獸醫分子診斷系統市場:依樣本類型分類

  • 血
  • 屎
  • 拭子
    • 鼻拭子
    • 口腔拭子
  • 組織
    • 肌肉組織
    • 器官切片檢查

第11章 獸醫分子診斷系統市場:依最終使用者分類

  • 診斷檢查室
    • 院內診斷
    • 獨立診斷
  • 研究機構
    • 學術實驗室
    • 受託研究機構
  • 獸醫醫院和診所
    • 多動物醫院
    • 小動物醫院

第12章 獸醫分子診斷系統市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸醫分子診斷系統市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫分子診斷系統市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Neogen Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • Seegene Inc.
  • Synbiotics Corporation
  • Thermo Fisher Scientific Inc.
  • Zoetis Inc.

第17章 主要專家

Product Code: MRR-1F6B55428653

The Veterinary Molecular Diagnostic System Market is projected to grow by USD 2.54 billion at a CAGR of 9.41% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.35 billion
Estimated Year [2026] USD 1.48 billion
Forecast Year [2032] USD 2.54 billion
CAGR (%) 9.41%

Veterinary Molecular Diagnostics: Executive Overview

Veterinary molecular diagnostic systems apply nucleic-acid testing and related molecular techniques to detect pathogens, genetic conditions, and clinically relevant biomarkers in animals. Their value is strongest where rapid, specific results can support treatment selection, herd management, outbreak control, food-chain protection, and surveillance across companion-animal, livestock, aquaculture, and wildlife settings.

Shifts Toward Faster, Decentralized Veterinary Testing

The landscape is shifting from centralized, laboratory-intensive workflows toward integrated systems that combine sample preparation, amplification, detection, and reporting with fewer manual steps. Demand for faster turnaround is reinforced by antimicrobial-resistance concerns, transboundary animal diseases, biosecurity requirements, and the need to manage high-throughput screening in production environments. Adoption also depends on sample quality, validation across species, workflow interoperability, operator training, reimbursement conditions, and regulatory acceptance.

Artificial Intelligence Enhances Interpretation and Workflow Control

Artificial intelligence can strengthen molecular diagnostics by supporting image and signal interpretation, quality-control checks, anomaly detection, epidemiological pattern recognition, and prioritization of confirmatory testing. Its practical contribution depends on representative veterinary datasets, transparent validation, human oversight, cybersecurity, and integration with laboratory information systems. AI is therefore most useful as an augmentation layer that improves consistency and triage rather than as a substitute for validated assays or veterinary judgment.

Regional Differences Reflect Disease Burden, Infrastructure, and Regulation

North America combines advanced veterinary infrastructure, established laboratory networks, and strong demand for companion-animal and livestock testing. Europe emphasizes animal-health surveillance, traceability, antimicrobial stewardship, and harmonized standards, while Asia-Pacific spans sophisticated urban diagnostics and rapidly developing production systems with varied laboratory capacity. Latin America places substantial emphasis on livestock health, export assurance, and outbreak monitoring. The Middle East faces distinctive priorities linked to livestock production, import controls, and transboundary disease preparedness. Africa presents significant opportunities for decentralized and field-adapted systems, although affordability, logistics, power reliability, and laboratory access remain important implementation considerations.

Group-Level Priorities Shape Procurement and Adoption

ASEAN priorities include cross-border surveillance, aquaculture and livestock health, and solutions suited to diverse laboratory environments. BRICS members reflect broad needs spanning large production systems, public veterinary services, research capacity, and uneven access to advanced testing. The European Union emphasizes harmonized surveillance, food safety, and regulatory alignment. G7 markets generally support sophisticated diagnostics, quality systems, and data integration. GCC countries prioritize import biosecurity, livestock productivity, and centralized or well-connected testing networks. NATO members may also value preparedness for biological threats affecting animal health, food security, and operational resilience, while national regulatory and procurement practices remain decisive.

Country Perspectives Highlight Diverse Use Cases

Australia emphasizes biosecurity, livestock surveillance, and geographically distributed testing. Brazil combines major livestock and poultry systems with needs for export-oriented diagnostics and outbreak control. Canada and the United States support advanced companion-animal, food-animal, research, and public-sector applications. China and India present broad demand across production animals, aquaculture, veterinary hospitals, and surveillance programs, with varied regional infrastructure. Japan and South Korea place importance on quality, speed, and technology-enabled clinical workflows. France, Germany, Italy, Spain, and the United Kingdom align molecular testing with animal-health services, food-chain assurance, research, and regulatory surveillance. Mexico prioritizes livestock health, trade-related testing, and improved regional access. Russia's requirements include large-scale production monitoring, veterinary control, and resilience across geographically dispersed systems.

Prioritize Validated, Connected, and Field-Ready Diagnostic Workflows

Industry leaders should first match assay menus and instrument formats to clearly defined species, diseases, sample types, and decision timelines. They should validate performance locally, establish quality-control and confirmatory-testing pathways, and design procurement around total workflow requirements rather than instrument features alone. Partnerships with veterinary laboratories, universities, producers, and public-health agencies can improve evidence generation and surveillance utility. Investments in interoperable reporting, workforce training, maintenance support, supply continuity, cybersecurity, and responsible AI governance will help convert technical capability into dependable clinical and population-health outcomes.

Methodology for a Evidence-Based Veterinary Diagnostic Assessment

This executive summary uses a structured review of the veterinary molecular diagnostic system landscape, organized around technology applications, animal-health workflows, regulatory and surveillance needs, infrastructure conditions, and regional implementation factors. Insights are synthesized from verifiable public information such as government and intergovernmental guidance, peer-reviewed research, regulatory materials, laboratory standards, and documented veterinary practice patterns. Claims are framed qualitatively to avoid unsupported estimates, and regional, group, and country observations are interpreted in light of differences in disease priorities, production systems, laboratory capacity, and policy environments.

Reliable Molecular Testing Supports More Resilient Animal Health Systems

Veterinary molecular diagnostic systems are increasingly important for timely detection, targeted intervention, antimicrobial stewardship, biosecurity, and coordinated surveillance. The strongest opportunities are likely to arise where validated assays, practical workflows, connected data systems, and trained users are combined with local disease knowledge and sustainable service models. Progress will depend less on technology alone than on fit with veterinary practice, regulatory expectations, infrastructure, and the operational realities of diverse animal-health settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Molecular Diagnostic System Market, by Disease Category

  • 7.1. Introduction
  • 7.2. Genetic Diseases
  • 7.3. Infectious Diseases
    • 7.3.1. Bacterial
      • 7.3.1.1. E coli
      • 7.3.1.2. Mycobacterium
      • 7.3.1.3. Salmonella
    • 7.3.2. Fungal
    • 7.3.3. Parasitic
    • 7.3.4. Viral
      • 7.3.4.1. Avian Influenza
      • 7.3.4.2. Equine Infectious Anemia
      • 7.3.4.3. Porcine Reproductive Respiratory Syndrome
  • 7.4. Metabolic Diseases
  • 7.5. Oncology Diagnostics

8. Veterinary Molecular Diagnostic System Market, by Technology

  • 8.1. Introduction
  • 8.2. Isothermal Amplification
  • 8.3. Next Generation Sequencing
  • 8.4. PCR
    • 8.4.1. Conventional PCR
    • 8.4.2. Digital PCR
    • 8.4.3. Real Time PCR

9. Veterinary Molecular Diagnostic System Market, by Species

  • 9.1. Introduction
  • 9.2. Companion Animals
    • 9.2.1. Canine
    • 9.2.2. Equine
    • 9.2.3. Feline
  • 9.3. Livestock
    • 9.3.1. Bovine
    • 9.3.2. Porcine
    • 9.3.3. Poultry

10. Veterinary Molecular Diagnostic System Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
  • 10.3. Fecal
  • 10.4. Swab
    • 10.4.1. Nasal Swab
    • 10.4.2. Oral Swab
  • 10.5. Tissue
    • 10.5.1. Muscle Tissue
    • 10.5.2. Organ Biopsy

11. Veterinary Molecular Diagnostic System Market, by End User

  • 11.1. Introduction
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital Based Diagnostics
    • 11.2.2. Standalone Diagnostics
  • 11.3. Research Institutes
    • 11.3.1. Academic Laboratories
    • 11.3.2. Contract Research Organizations
  • 11.4. Veterinary Hospitals & Clinics
    • 11.4.1. Mixed Animal Hospitals
    • 11.4.2. Small Animal Hospitals

12. Veterinary Molecular Diagnostic System Market, by Region

  • 12.1. Introduction
  • 12.2. Asia-Pacific
  • 12.3. North America
  • 12.4. Latin America
  • 12.5. Europe
  • 12.6. Middle East
  • 12.7. Africa

13. Veterinary Molecular Diagnostic System Market, by Group

  • 13.1. Introduction
  • 13.2. ASEAN
  • 13.3. GCC
  • 13.4. European Union
  • 13.5. BRICS
  • 13.6. G7
  • 13.7. NATO

14. Veterinary Molecular Diagnostic System Market, by Country

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. United Kingdom
  • 14.7. Germany
  • 14.8. France
  • 14.9. Russia
  • 14.10. Italy
  • 14.11. Spain
  • 14.12. China
  • 14.13. India
  • 14.14. Japan
  • 14.15. Australia
  • 14.16. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. Market Concentration Analysis, 2025
    • 15.2.1. Concentration Ratio (CR)
    • 15.2.2. Herfindahl Hirschman Index (HHI)
  • 15.3. Recent Developments & Impact Analysis, 2025
  • 15.4. Product Portfolio Analysis, 2025
  • 15.5. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Bio-Rad Laboratories, Inc.
  • 16.3. IDEXX Laboratories, Inc.
  • 16.4. Merck & Co., Inc.
  • 16.5. Neogen Corporation
  • 16.6. PerkinElmer, Inc.
  • 16.7. QIAGEN N.V.
  • 16.8. Seegene Inc.
  • 16.9. Synbiotics Corporation
  • 16.10. Thermo Fisher Scientific Inc.
  • 16.11. Zoetis Inc.

17. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Veterinary Molecular Diagnostic System Market, Years Considered for the Study
  • FIGURE 2. Global Veterinary Molecular Diagnostic System Market, Research Design
  • FIGURE 3. Global Veterinary Molecular Diagnostic System Market, Research Framework
  • FIGURE 4. Global Veterinary Molecular Diagnostic System Market, Data Triangulation
  • FIGURE 5. Global Veterinary Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2025 vs 2032 (%)
  • FIGURE 7. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 9. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2025 vs 2032 (%)
  • FIGURE 11. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 15. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 17. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Veterinary Molecular Diagnostic System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Veterinary Molecular Diagnostic System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 20. Global Veterinary Molecular Diagnostic System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Veterinary Molecular Diagnostic System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Veterinary Molecular Diagnostic System Market Segmentation & Coverage
  • TABLE 2. Global Veterinary Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 4. Global Genetic Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Genetic Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Genetic Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global E coli Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global E coli Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global E coli Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Mycobacterium Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Mycobacterium Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Mycobacterium Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Salmonella Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Salmonella Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Salmonella Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Viral Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Viral Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Viral Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Avian Influenza Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Avian Influenza Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Avian Influenza Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Equine Infectious Anemia Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Equine Infectious Anemia Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Equine Infectious Anemia Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Porcine Reproductive Respiratory Syndrome Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Porcine Reproductive Respiratory Syndrome Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Porcine Reproductive Respiratory Syndrome Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Metabolic Diseases Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Metabolic Diseases Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Metabolic Diseases Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Oncology Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Oncology Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Oncology Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 47. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Conventional PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Conventional PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Conventional PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Real Time PCR Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Real Time PCR Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Real Time PCR Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 66. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 67. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 68. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 69. Global Canine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 70. Global Canine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 71. Global Canine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 72. Global Equine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Equine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Equine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Feline Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Feline Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Feline Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Bovine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Bovine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Bovine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Porcine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Porcine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Porcine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 91. Global Blood Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. Global Blood Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 93. Global Blood Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 94. Global Fecal Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 95. Global Fecal Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 96. Global Fecal Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 97. Global Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 98. Global Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 99. Global Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 100. Global Nasal Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 101. Global Nasal Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 102. Global Nasal Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 103. Global Oral Swab Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 104. Global Oral Swab Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 105. Global Oral Swab Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 106. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 107. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 108. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 109. Global Muscle Tissue Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 110. Global Muscle Tissue Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 111. Global Muscle Tissue Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 112. Global Organ Biopsy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Global Organ Biopsy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. Global Organ Biopsy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 115. Global Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 116. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 117. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 118. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 119. Global Hospital Based Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 120. Global Hospital Based Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 121. Global Hospital Based Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 122. Global Standalone Diagnostics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 123. Global Standalone Diagnostics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 124. Global Standalone Diagnostics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 125. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 126. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 127. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 128. Global Academic Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 129. Global Academic Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 130. Global Academic Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 131. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 132. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 133. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 134. Global Veterinary Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 135. Global Veterinary Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 136. Global Veterinary Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 137. Global Mixed Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 138. Global Mixed Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 139. Global Mixed Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 140. Global Small Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Global Small Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 142. Global Small Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 143. Global Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 145. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 146. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 147. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 148. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 149. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 150. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 151. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 152. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 153. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 154. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 155. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 156. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 157. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 158. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 159. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 160. Asia-Pacific Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 161. North America Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 162. North America Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 163. North America Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 164. North America Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 165. North America Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 166. North America Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 167. North America Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 168. North America Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 169. North America Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 170. North America Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 171. North America Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 172. North America Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 173. North America Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 174. North America Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 175. North America Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 176. North America Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 177. North America Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 178. Latin America Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 179. Latin America Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 180. Latin America Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 181. Latin America Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 182. Latin America Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 183. Latin America Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 184. Latin America Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 185. Latin America Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 186. Latin America Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 187. Latin America Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 188. Latin America Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 189. Latin America Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 190. Latin America Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 191. Latin America Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 192. Latin America Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 193. Latin America Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 194. Latin America Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 195. Europe Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 196. Europe Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 197. Europe Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 198. Europe Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 199. Europe Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 200. Europe Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 201. Europe Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 202. Europe Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 203. Europe Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 204. Europe Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 205. Europe Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 206. Europe Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 207. Europe Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 208. Europe Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Europe Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 210. Europe Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 211. Europe Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 212. Middle East Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 213. Middle East Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 214. Middle East Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 215. Middle East Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 216. Middle East Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 217. Middle East Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 218. Middle East Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 219. Middle East Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 220. Middle East Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 221. Middle East Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 222. Middle East Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 223. Middle East Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 224. Middle East Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 225. Middle East Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 226. Middle East Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 227. Middle East Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 228. Middle East Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 229. Africa Veterinary Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 230. Africa Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 231. Africa Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 232. Africa Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 233. Africa Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 234. Africa Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 235. Africa Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 236. Africa Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 237. Africa Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 238. Africa Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 239. Africa Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 240. Africa Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 241. Africa Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 242. Africa Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 243. Africa Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 244. Africa Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 245. Africa Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 246. Global Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 247. ASEAN Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 248. ASEAN Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 249. ASEAN Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 250. ASEAN Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 251. ASEAN Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 252. ASEAN Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 253. ASEAN Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 254. ASEAN Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 255. ASEAN Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 256. ASEAN Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 257. ASEAN Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 258. ASEAN Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 259. ASEAN Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 260. ASEAN Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 261. ASEAN Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 262. ASEAN Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 263. ASEAN Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 264. GCC Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 265. GCC Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 266. GCC Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 267. GCC Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 268. GCC Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 269. GCC Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 270. GCC Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 271. GCC Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 272. GCC Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 273. GCC Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 274. GCC Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 275. GCC Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 276. GCC Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 277. GCC Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 278. GCC Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 279. GCC Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 280. GCC Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 281. European Union Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 282. European Union Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 283. European Union Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 284. European Union Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 285. European Union Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 286. European Union Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 287. European Union Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 288. European Union Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 289. European Union Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 290. European Union Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 291. European Union Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 292. European Union Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 293. European Union Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 294. European Union Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 295. European Union Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 296. European Union Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 297. European Union Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 298. BRICS Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 299. BRICS Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 300. BRICS Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 301. BRICS Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 302. BRICS Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 303. BRICS Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 304. BRICS Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 305. BRICS Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 306. BRICS Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 307. BRICS Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 308. BRICS Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 309. BRICS Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 310. BRICS Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 311. BRICS Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 312. BRICS Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 313. BRICS Veterinary Molecular Diagnostic System Market Size, by Research Institutes, 2017-2032 (USD Million)
  • TABLE 314. BRICS Veterinary Molecular Diagnostic System Market Size, by Veterinary Hospitals & Clinics, 2017-2032 (USD Million)
  • TABLE 315. G7 Veterinary Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 316. G7 Veterinary Molecular Diagnostic System Market Size, by Disease Category, 2017-2032 (USD Million)
  • TABLE 317. G7 Veterinary Molecular Diagnostic System Market Size, by Infectious Diseases, 2017-2032 (USD Million)
  • TABLE 318. G7 Veterinary Molecular Diagnostic System Market Size, by Bacterial, 2017-2032 (USD Million)
  • TABLE 319. G7 Veterinary Molecular Diagnostic System Market Size, by Viral, 2017-2032 (USD Million)
  • TABLE 320. G7 Veterinary Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 321. G7 Veterinary Molecular Diagnostic System Market Size, by PCR, 2017-2032 (USD Million)
  • TABLE 322. G7 Veterinary Molecular Diagnostic System Market Size, by Species, 2017-2032 (USD Million)
  • TABLE 323. G7 Veterinary Molecular Diagnostic System Market Size, by Companion Animals, 2017-2032 (USD Million)
  • TABLE 324. G7 Veterinary Molecular Diagnostic System Market Size, by Livestock, 2017-2032 (USD Million)
  • TABLE 325. G7 Veterinary Molecular Diagnostic System Market Size, by Sample Type, 2017-2032 (USD Million)
  • TABLE 326. G7 Veterinary Molecular Diagnostic System Market Size, by Swab, 2017-2032 (USD Million)
  • TABLE 327. G7 Veterinary Molecular Diagnostic System Market Size, by Tissue, 2017-2032 (USD Million)
  • TABLE 328. G7 Veterinary Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 329. G7 Veterinary Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
  • TABLE 330. G7 Veterinary Molecular Diagnostic S